ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

AUA Funds Three Innovative Projects Through Its Data Research Program to Advance Urological Research

BALTIMORE, March 05, 2026 (GLOBE NEWSWIRE) -- The American Urological Association (AUA) has announced the three 2026 selections for its Data Research Program, funding innovative studies that use real‑world data to advance urological care and workforce insights.

The AUA Data Research Program launched in May 2023 and supports up to six research projects annually using data from AUA Data Repositories to address key knowledge gaps and emerging research questions related to urological care, workforce development, and health policy.

“We are excited to continue to broaden the capabilities and reach of the Data Research Program as we fund three impactful projects for 2026. We congratulate the investigators and look forward to having the AUA partner with them to address the important research questions in their work,” said Richard S. Matulewicz, MD, MSCI, MS, chair of the AUA Data Research Program.

Awardees conduct clinical and workforce studies using real-world clinical data from the AUA Quality (AQUA) Registry and population-representative AUA Annual Census data. The AUA provides complimentary data access, full analytical support from AUA statisticians, assistance with developing methodology for abstracts and publications, and a $2,000 stipend to cover costs for knowledge dissemination.

“In year three of the Data Research Program relaunch, we are excited to explore new disease conditions. This highlights the AUA commitment, along with partner Verana Health, to cultivate novel data solutions to advance the field of urology,” said Ray Tan, MD, MSHPM, chair of the AUA Data Committee. “The next cycle of the Data Research Program will include a special opportunity for investigators to propose new questions for inclusion in the 2027 AUA Annual Census. This option is designed to address emerging policy or workforce needs and will provide researchers with targeted, timely data to support their research efforts.”

Congratulations to the 2026 awardees:

Principal Investigator Divya Ajay, MD, MPH, will receive this award for an AQUA data project titled, “Vaginal Estrogen in Women Cancer Survivors with Recurrent UTIs and Overactive Bladder: Trends, Determinants, and Outcomes in Urology”.

Principal Investigator Kenneth Softness, MD, and co-investigator Caleb Nelson, MD, MPH, will receive this award for an AQUA data project titled, “Access gaps in Beta-3 Agonist Therapy in Neurogenic Bladder using the AQUA Registry”.

Principal Investigator Connor O’Leary, BA, and co-investigators Saum Ghodoussipour, MD; Vignesh Packiam, MD; Thomas Jang, MD; and Hari Iyer, MD, will receive this award for an AQUA data project titled, “Evaluating and enhancing risk stratification models and intravesical therapies for non-muscle invasive bladder cancer (NMIBC) using U.S. Real-World.”

To learn more about the AUA Data Research Program visit https://www.auanet.org/dataresearchprogram.

About the American Urological Association: Founded in 1902 and headquartered near Baltimore, Maryland, the American Urological Association is a leading advocate for the specialty of urology and has nearly 25,000 members throughout the world. The AUA is a premier urologic association, providing invaluable support to the urologic community as it pursues its mission of fostering the highest standards of urologic care through education, research and the formulation of health policy.

Attachment


Corey Del Bianco
American Urological Association
443-909-4033
cdelbianco@auanet.org

Recent Quotes

View More
Symbol Price Change (%)
AMZN  209.10
+1.44 (0.69%)
AAPL  252.86
+2.74 (1.10%)
AMD  199.19
+5.80 (3.00%)
BAC  47.21
+0.49 (1.05%)
GOOG  302.68
+1.22 (0.40%)
META  625.80
+12.09 (1.97%)
MSFT  398.50
+2.95 (0.75%)
NVDA  184.09
+3.84 (2.13%)
ORCL  156.50
+1.39 (0.90%)
TSLA  398.33
+7.13 (1.82%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.